Historical setup
What FY25 said to watch
From Reported PBT fell 21.1% while cash conversion rose to 75.3%
EBOS confirmed underlying EBITDA of $585m, inside the disclosed range of $575–600m. No forward targets were supplied in the extraction, so this briefing focuses on what the release does and does not support. The HY25 share of FY25 was 48.8% of revenue, 49.6% of EBITDA and 51.4% of NPAT, indicating broadly balanced halves with a marginally softer H2 NPAT.
The release does not provide quantified FY26 guidance. The gap between the 12.0% underlying revenue growth signal and the 15.1% underlying NPAT decline means the forward shape — particularly margin and finance-cost recovery — remains an open question.